Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
MicroRNA-21 (miR-21)
100%
Myelodysplastic Syndrome
100%
Therapeutic Targeting
100%
TGF Signaling
25%
Stem Cells
25%
Primary Myelodysplastic Syndrome
25%
Smad7
18%
Clinically Significant
12%
Ineffective Hematopoiesis
12%
Overexpression
12%
Bone Marrow Failure
12%
Red Cells
12%
STAT3 Expression
6%
Bone Marrow Progenitor
6%
Anemia
6%
Negative Regulator
6%
Cell Proliferation
6%
GTPase
6%
Hematopoiesis
6%
TGF-β Receptor
6%
Exchange Factor
6%
Cytopenia
6%
Membrane Formation
6%
Effective Treatment
6%
Gene Amplification
6%
Human Erythropoiesis
6%
Patient Characteristics
6%
Smad2
6%
Xenograft
6%
Constitutive Activation
6%
Cell Differentiation
6%
Pyrimethamine
6%
Stem Cell Deficiency
6%
Overactivation
6%
Functional Role
6%
Pathogenic Genes
6%
Signaling Pathway
6%
Dysplasia
6%
Hematopoietic Stem Cells
6%
Biochemical Approaches
6%
Downstream Effectors
6%
Myelosuppression
6%
Red Cell Membrane
6%
Epigenetic Modification
6%
Blood Count
6%
Molecular Pathways
6%
Acute Leukemia
6%
DOCK4
6%
Hematological Malignancies
6%
In Vitro Model
6%
Transgenic Mouse Model
6%
Functional Approach
6%
STAT3 Inhibitor
6%
Molecular Alterations
6%
Antisense Inhibitor
6%
Mouse Model
6%
Pharmacology, Toxicology and Pharmaceutical Science
microRNA 21
100%
Myelodysplastic Syndrome
100%
Cytokine
10%
Bone Marrow Depression
10%
Mouse Model
10%
Guanosine Triphosphatase
5%
Dysplasia
5%
Phosphotransferase
5%
Hematologic Malignancy
5%
Cytopenia
5%
Transgenic Mouse
5%
Acute Leukemia
5%
Anemia
5%
Pyrimethamine
5%
Receptor
5%